Safety and Feasibility of the Use of Natural Killer Cells in Patients With Chronic Myeloid Leukemia

NCT03348033 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
5
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Hospital de Clinicas de Porto Alegre